Indication
Proopiomelanocortin Deficiency Obesity
2 clinical trials
2 products
Product
SetmelanotideClinical trial
A Phase 3 Multi-Center, One-Year, Open-Label Study of Setmelanotide in Pediatric Patients Aged 2 to <6 Years of Age With Rare Genetic Causes of ObesityStatus: Completed, Estimated PCD: 2023-09-19
Clinical trial
A Phase 2, Single-arm, Open-label Study to Assess Efficacy and Safety of LB54640 in Patients With Obesity Due to POMC, PCSK1, or LEPR Deficiency.Status: Not yet recruiting, Estimated PCD: 2024-12-01
Product
LB54640